Prescription n-3 Fatty Acids, But Not Eicosapentaenoic Acid Alone, Improve Reference Memory-Related Learning Ability by Increasing Brain-Derived Neurotrophic Factor Levels in SHR.Cg-Lepr cp /NDmcr rats, A Metabolic Syndrome Model
Open Access
- 21 August 2013
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 38 (10) , 2124-2135
Abstract
Metabolic syndrome is implicated in the decline of cognitive ability. We investigated whether the prescription n-3 fatty acid administration improves cognitive learning ability in SHR.Cg-Lepr cp/NDmcr (SHR-cp) rats, a metabolic syndrome model, in comparison with administration of eicosapentaenoic acid (EPA, C20:5, n-3) alone. Administration of TAK-085 [highly purified and concentrated n-3 fatty acid formulation containing EPA ethyl ester and docosahexaenoic acid (DHA, C22:6, n-3) ethyl ester] at 300 mg/kg body weight per day for 13 weeks reduced the number of reference memory-related errors in SHR-cp rats, but EPA alone had no effect, suggesting that long-term TAK-085 administration improves cognitive learning ability in a rat model of metabolic syndrome. However, the working memory-related errors were not affected in either of the rat groups. TAK-085 and EPA administration increased plasma EPA and DHA levels of SHR-cp rats, associating with an increase in EPA and DHA in the cerebral cortex. The TAK-085 administration decreased the lipid peroxide levels and reactive oxygen species in the cerebral cortex and hippocampus of SHR-cp rats, suggesting that TAK-085 increases antioxidative defenses. Its administration also increased the brain-derived neurotrophic factor levels in the cortical and hippocampal tissues of TAK-085-administered rats. The present study suggests that long-term TAK-085 administration is a possible therapeutic strategy for protecting against metabolic syndrome-induced learning decline.Keywords
This publication has 52 references indexed in Scilit:
- (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?The Journal of Nutrition, 2012
- The Salutary Effects of DHA Dietary Supplementation on Cognition, Neuroplasticity, and Membrane Homeostasis after Brain TraumaJournal of Neurotrauma, 2011
- Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-AnalysisJournal of the American Academy of Child & Adolescent Psychiatry, 2011
- Docosahexaenoic Acid Signalolipidomics in Nutrition: Significance in Aging, Neuroinflammation, Macular Degeneration, Alzheimer's, and Other Neurodegenerative DiseasesAnnual Review of Nutrition, 2011
- Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on AgeingJournal of Neurology, Neurosurgery & Psychiatry, 2009
- The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid β(1–40)The Journal of Nutritional Biochemistry, 2009
- Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular DementiaDiabetes Care, 2009
- Docosahexaenoic acid alters the size and distribution of cell surface microdomainsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid β-infused rats relates to the decreases of amyloid β and cholesterol levels in detergent-insoluble membrane fractionsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Impaired Maze Learning and Cerebral Glucose Utilization in Aged Hypertensive RatsHypertension, 1995